JP2017522357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522357A5 JP2017522357A5 JP2017505480A JP2017505480A JP2017522357A5 JP 2017522357 A5 JP2017522357 A5 JP 2017522357A5 JP 2017505480 A JP2017505480 A JP 2017505480A JP 2017505480 A JP2017505480 A JP 2017505480A JP 2017522357 A5 JP2017522357 A5 JP 2017522357A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- preparing
- thf
- including methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 94
- 238000000034 method Methods 0.000 claims 37
- 238000004519 manufacturing process Methods 0.000 claims 20
- 239000000203 mixture Substances 0.000 claims 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 12
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 claims 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 9
- 239000012442 inert solvent Substances 0.000 claims 8
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 5
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 5
- 230000003197 catalytic effect Effects 0.000 claims 5
- 238000005580 one pot reaction Methods 0.000 claims 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 4
- 238000010992 reflux Methods 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 238000003756 stirring Methods 0.000 claims 4
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 claims 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 3
- 229960000583 acetic acid Drugs 0.000 claims 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 2
- 239000012362 glacial acetic acid Substances 0.000 claims 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims 1
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 150000004702 methyl esters Chemical class 0.000 claims 1
- 0 C*c1c(C=C(C(C)=O)C(OCCC#N)=O)ccc(C#N)c1 Chemical compound C*c1c(C=C(C(C)=O)C(OCCC#N)=O)ccc(C#N)c1 0.000 description 1
- RFJLQSVKIAMLCX-NTEUORMPSA-N CC(/C(/C(OCCC#N)=O)=C\c(ccc(C#N)c1)c1OC)=O Chemical compound CC(/C(/C(OCCC#N)=O)=C\c(ccc(C#N)c1)c1OC)=O RFJLQSVKIAMLCX-NTEUORMPSA-N 0.000 description 1
- WWAABAWXHRNWCT-UHFFFAOYSA-N CC(C(C(I)=O)C(OC)=C1)C=C1[Zn] Chemical compound CC(C(C(I)=O)C(OC)=C1)C=C1[Zn] WWAABAWXHRNWCT-UHFFFAOYSA-N 0.000 description 1
- SMWPNASNQIIBDW-UHFFFAOYSA-N CC(C1=C2C(c(ccc(N)c3)c3OC)C(C(OCCN)=O)=C(C)N1)=CNC2=O Chemical compound CC(C1=C2C(c(ccc(N)c3)c3OC)C(C(OCCN)=O)=C(C)N1)=CNC2=O SMWPNASNQIIBDW-UHFFFAOYSA-N 0.000 description 1
- WUPRJMHPZJWLHY-YYBBLCMGSA-N CCOc1ncc(C)c2c1[C@H](C(/C(/OC)=C\C(\C#N)=C/C)=C)C(C(N)=O)=C(C)N2 Chemical compound CCOc1ncc(C)c2c1[C@H](C(/C(/OC)=C\C(\C#N)=C/C)=C)C(C(N)=O)=C(C)N2 WUPRJMHPZJWLHY-YYBBLCMGSA-N 0.000 description 1
- ZXENVSJZOHXCKL-UHFFFAOYSA-N COc1c(C=O)ccc(C#N)c1 Chemical compound COc1c(C=O)ccc(C#N)c1 ZXENVSJZOHXCKL-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14179544 | 2014-08-01 | ||
| EP14179544.3 | 2014-08-01 | ||
| PCT/EP2015/067340 WO2016016287A1 (de) | 2014-08-01 | 2015-07-29 | Verfahren zur herstellung von (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carbox-amid und dessen aufreinigung für die verwendung als pharmazeutischer wirkstoff |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522357A JP2017522357A (ja) | 2017-08-10 |
| JP2017522357A5 true JP2017522357A5 (enExample) | 2018-09-06 |
| JP6818674B2 JP6818674B2 (ja) | 2021-01-20 |
Family
ID=51260727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017505480A Active JP6818674B2 (ja) | 2014-08-01 | 2015-07-29 | （４ｓ）−４−（４−シアノ−２−メトキシフェニル）−５−エトキシ−２，８−ジメチル−１，４−ジヒドロ−１，６−ナフチリジン−３−カルボキサミドを調製するための方法および医薬品有効成分としての使用のためのその精製 |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | USRE49575E1 (enExample) |
| EP (2) | EP3660015A1 (enExample) |
| JP (1) | JP6818674B2 (enExample) |
| KR (3) | KR102527893B1 (enExample) |
| CN (3) | CN116655627A (enExample) |
| AR (1) | AR101403A1 (enExample) |
| AU (1) | AU2015295376C1 (enExample) |
| BR (1) | BR112017001678B1 (enExample) |
| CA (2) | CA2956529A1 (enExample) |
| CL (1) | CL2017000263A1 (enExample) |
| CO (1) | CO2017000886A2 (enExample) |
| DK (1) | DK3174875T3 (enExample) |
| ES (1) | ES2828704T3 (enExample) |
| HR (1) | HRP20201800T1 (enExample) |
| HU (1) | HUE051350T2 (enExample) |
| IL (1) | IL250239B (enExample) |
| JO (1) | JO3648B1 (enExample) |
| LT (1) | LT3174875T (enExample) |
| MX (1) | MX369467B (enExample) |
| MY (1) | MY198066A (enExample) |
| PE (1) | PE20170141A1 (enExample) |
| PL (1) | PL3174875T3 (enExample) |
| PT (1) | PT3174875T (enExample) |
| RS (1) | RS60921B1 (enExample) |
| RU (1) | RU2729998C9 (enExample) |
| SG (1) | SG11201700785UA (enExample) |
| SI (1) | SI3174875T1 (enExample) |
| TW (1) | TWI684593B (enExample) |
| UA (1) | UA122773C2 (enExample) |
| UY (1) | UY36251A (enExample) |
| WO (1) | WO2016016287A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116655627A (zh) * | 2014-08-01 | 2023-08-29 | 拜耳医药股份有限公司 | 一种化合物的制备方法及其纯化以用作活性药物成分 |
| LT3337800T (lt) | 2015-08-21 | 2019-08-12 | Bayer Pharma Aktiengesellschaft | (4s)-4-(4-ciano-2-metoksifenil)-5-etoksi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-karboksamido, skirto naudoti kaip veikliojo farmacinio ingrediento, gamybos būdas ir gryninimas |
| EP3560922A1 (de) | 2018-04-24 | 2019-10-30 | Bayer Aktiengesellschaft | Verfahren zur herstellung von (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carbox-amid durch racemat-spaltung mittels diastereomerer weinsäureester |
| JOP20210243A1 (ar) | 2019-03-05 | 2023-01-30 | Bayer Ag | طريقة لتحضير 4-أمينو-5-مثيل بيريدون |
| BR112021014815A2 (pt) | 2019-03-05 | 2021-09-28 | Bayer Aktiengesellschaft | Método para preparação de 4-amino-5-metilpiridona |
| CN114555599B (zh) * | 2019-10-17 | 2024-06-07 | 拜耳公司 | 制备(4s)-(4-氰基-2-甲氧基苯基)-5-乙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-羧酸的酰氧基甲基酯的方法 |
| CA3158167A1 (en) * | 2019-10-17 | 2021-04-22 | Bayer Aktiengesellschaft | Photochemical process for producing (4r,4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamide |
| IL292192A (en) * | 2019-10-17 | 2022-06-01 | Bayer Ag | Process for the preparation of (2-cyanoethyl(4s)-4-(4-cyano-2-methoxy-phenyl)-5-hydroxy-8,2-dimethyl-4,1-dihydro-6,1-naphthyridine-3-carboxylate By separating the racemate using tartaric acid esters and diastereomers |
| MX2022004467A (es) * | 2019-10-17 | 2022-05-03 | Bayer Ag | Procedimiento para preparar (4s)-4-(4-ciano-2-metoxi-fenil)-5-etox i-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-carboxilato de 2-cianoetilo mediante separacion de racematos utilizando esteres diastereomericos de acido tartarico. |
| EP3900722A1 (en) | 2020-04-22 | 2021-10-27 | Bayer AG | Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular and/or renal diseases |
| WO2021214023A1 (en) | 2020-04-22 | 2021-10-28 | Bayer Aktiengesellschaft | Combination of finerenone and a sglt2 inhibitor for the treatment and/or prevention of cardiovascular and/or renal diseases |
| WO2021254896A1 (en) | 2020-06-16 | 2021-12-23 | Bayer Aktiengesellschaft | Process for preparing (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide enabled by a catalytic asymmetric hantzsch ester reduction |
| CN112237573B (zh) * | 2020-10-29 | 2023-12-22 | 瑞阳制药股份有限公司 | 含finerenone的片剂及其制备方法 |
| WO2022214206A1 (en) | 2021-04-08 | 2022-10-13 | Bayer Aktiengesellschaft | Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular and/or renal diseases |
| CN114149427A (zh) * | 2021-12-18 | 2022-03-08 | 上海鼎雅药物化学科技有限公司 | 非奈利酮及其中间体的合成方法 |
| CN115340539B (zh) | 2022-01-19 | 2024-02-27 | 奥锐特药业股份有限公司 | 制备非奈利酮及其中间体的方法 |
| CN115340540A (zh) * | 2022-01-20 | 2022-11-15 | 奥锐特药业股份有限公司 | 制备非奈利酮及其中间体的方法 |
| CN114524812A (zh) * | 2022-03-18 | 2022-05-24 | 湖南凯铂生物药业有限公司 | 1,4-二氢-1,6-萘啶化合物的晶型制备以及合成方法 |
| US20250270184A1 (en) | 2022-04-18 | 2025-08-28 | Teva Pharmaceuticals International Gmbh | Processes for the preparation of finerenone |
| EP4286368A1 (de) | 2022-05-31 | 2023-12-06 | Bayer Aktiengesellschaft | Verfahren zur herstellung von 4-formyl-3-methoxybenzonitril |
| WO2024075139A1 (en) * | 2022-10-06 | 2024-04-11 | Maithri Drugs Private Limited | A process for preparation of finerenone and intermediates thereof |
| KR20250099382A (ko) | 2022-11-04 | 2025-07-01 | 난징 브이케어 파마테크 씨오., 엘티디. | 부분입체 이성질체 타르타르산 에스테르를 이용하여 라세미체를 분리하여 피네레논을 제조하는 방법 |
| JP2025536789A (ja) * | 2022-11-23 | 2025-11-07 | バイエル アクチェンゲゼルシャフト | １型糖尿病における慢性腎臓病の治療 |
| EP4634179A1 (en) | 2022-12-16 | 2025-10-22 | Bayer Aktiengesellschaft | Sequential one-pot synthesis for preparing 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide |
| WO2024147053A1 (en) * | 2023-01-03 | 2024-07-11 | Optimus Drugs Pvt Ltd | Improved process for the preparation of finerenone |
| TW202438065A (zh) * | 2023-03-17 | 2024-10-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | 1,4-二氫-1,6-萘啶醯胺化合物的可藥用鹽、晶型及其製備方法 |
| WO2025104752A1 (en) * | 2023-11-18 | 2025-05-22 | Msn Laboratories Private Limited, R&D Center | Improved process for the preparation of (4s)4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide |
| CN120081840A (zh) * | 2023-12-01 | 2025-06-03 | 山东诚创蓝海医药科技有限公司 | 一种非奈利酮-马来酸共晶及其制备方法 |
| US20250313559A1 (en) | 2024-01-05 | 2025-10-09 | Bayer Aktiengesellschaft | Method of preventing or treating heart failure in a patient using (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide |
| WO2025247801A1 (en) * | 2024-05-30 | 2025-12-04 | Bayer Aktiengesellschaft | Determination of a dosage of a nonsteroidal mineralocorticoid receptor antagonist |
| CN119462643A (zh) * | 2024-10-17 | 2025-02-18 | 河北国龙制药有限公司 | 一种非奈利酮单晶及其制备方法和应用 |
| CN119019395A (zh) * | 2024-10-29 | 2024-11-26 | 成都诺和晟欣生物医药有限公司 | 一种非奈利酮晶型ⅰ的制备方法 |
| CN119684289A (zh) * | 2024-12-18 | 2025-03-25 | 安徽先和医药研究有限公司 | 一种非奈利酮的制备方法 |
| CN119684288A (zh) * | 2024-12-18 | 2025-03-25 | 安徽先和医药研究有限公司 | 非奈利酮的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL75987A (en) * | 1984-08-25 | 1991-07-18 | Goedecke Ag | Tri-and tetrasubstituted-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them |
| US4895860A (en) * | 1989-04-21 | 1990-01-23 | American Home Products Corporation | Novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides useful as anthihyperglycemic agents |
| DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
| DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
| GB9914825D0 (en) | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
| DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| DE19943639A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften |
| DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
| DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
| DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
| JP2008516978A (ja) * | 2004-10-15 | 2008-05-22 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 肥満症の処置のためのビフェニル−４−イル−カルボニルアミノ酸誘導体の製造および使用 |
| WO2006060461A1 (en) * | 2004-12-03 | 2006-06-08 | Schering Corporation | Substituted piperazines as cb1 antagonists |
| AU2006201739A1 (en) * | 2005-05-05 | 2006-11-23 | The University Of North Carolina At Chapel Hill | Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles |
| EP1902022A1 (en) | 2005-07-12 | 2008-03-26 | Glaxo Group Limited | Piperazine heteroaryl derivates as gpr38 agonists |
| DE102006026583A1 (de) | 2006-06-07 | 2007-12-13 | Bayer Healthcare Aktiengesellschaft | Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung |
| DE102006044696A1 (de) | 2006-09-22 | 2008-03-27 | Bayer Healthcare Ag | 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung |
| DE102007009494A1 (de) | 2007-02-27 | 2008-08-28 | Bayer Healthcare Ag | Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung |
| CN102020587A (zh) | 2010-11-25 | 2011-04-20 | 大连凯飞精细化工有限公司 | 2-甲氧基-4-氰基苯甲醛的合成方法 |
| CN116655627A (zh) * | 2014-08-01 | 2023-08-29 | 拜耳医药股份有限公司 | 一种化合物的制备方法及其纯化以用作活性药物成分 |
-
2015
- 2015-07-29 CN CN202310616268.7A patent/CN116655627A/zh active Pending
- 2015-07-29 WO PCT/EP2015/067340 patent/WO2016016287A1/de not_active Ceased
- 2015-07-29 RU RU2017106602A patent/RU2729998C9/ru active
- 2015-07-29 PL PL15742306T patent/PL3174875T3/pl unknown
- 2015-07-29 SI SI201531406T patent/SI3174875T1/sl unknown
- 2015-07-29 HU HUE15742306A patent/HUE051350T2/hu unknown
- 2015-07-29 CA CA2956529A patent/CA2956529A1/en active Pending
- 2015-07-29 DK DK15742306.2T patent/DK3174875T3/da active
- 2015-07-29 EP EP19213735.4A patent/EP3660015A1/de not_active Withdrawn
- 2015-07-29 BR BR112017001678-8A patent/BR112017001678B1/pt active IP Right Grant
- 2015-07-29 KR KR1020177005278A patent/KR102527893B1/ko active Active
- 2015-07-29 LT LTEP15742306.2T patent/LT3174875T/lt unknown
- 2015-07-29 SG SG11201700785UA patent/SG11201700785UA/en unknown
- 2015-07-29 MX MX2017001507A patent/MX369467B/es active IP Right Grant
- 2015-07-29 US US17/002,115 patent/USRE49575E1/en active Active
- 2015-07-29 MY MYPI2017700334A patent/MY198066A/en unknown
- 2015-07-29 RS RS20201213A patent/RS60921B1/sr unknown
- 2015-07-29 KR KR1020237014295A patent/KR102830206B1/ko active Active
- 2015-07-29 HR HRP20201800TT patent/HRP20201800T1/hr unknown
- 2015-07-29 AU AU2015295376A patent/AU2015295376C1/en active Active
- 2015-07-29 CN CN202310619597.7A patent/CN116655629A/zh active Pending
- 2015-07-29 PT PT157423062T patent/PT3174875T/pt unknown
- 2015-07-29 ES ES15742306T patent/ES2828704T3/es active Active
- 2015-07-29 JP JP2017505480A patent/JP6818674B2/ja active Active
- 2015-07-29 CN CN201580053456.7A patent/CN106795155B/zh active Active
- 2015-07-29 PE PE2017000143A patent/PE20170141A1/es unknown
- 2015-07-29 KR KR1020257022052A patent/KR20250108757A/ko active Pending
- 2015-07-29 CA CA3146285A patent/CA3146285C/en active Active
- 2015-07-29 EP EP15742306.2A patent/EP3174875B1/de active Active
- 2015-07-29 UA UAA201701875A patent/UA122773C2/uk unknown
- 2015-07-29 US US15/329,043 patent/US10059707B2/en not_active Ceased
- 2015-07-30 TW TW104124689A patent/TWI684593B/zh active
- 2015-07-30 JO JOP/2015/0184A patent/JO3648B1/ar active
- 2015-07-31 UY UY0001036251A patent/UY36251A/es not_active Application Discontinuation
- 2015-07-31 AR ARP150102475A patent/AR101403A1/es unknown
-
2017
- 2017-01-23 IL IL250239A patent/IL250239B/en active IP Right Grant
- 2017-01-31 CL CL2017000263A patent/CL2017000263A1/es unknown
- 2017-01-31 CO CONC2017/0000886A patent/CO2017000886A2/es unknown
-
2018
- 2018-08-27 US US16/114,198 patent/US10399977B2/en not_active Ceased
-
2020
- 2020-11-03 US US17/087,659 patent/USRE49860E1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522357A5 (enExample) | ||
| HRP20201800T1 (hr) | Postupak za pripravu (4s)-4-(4-cijano-2-metoksifenil)-5-etoksi-2,8-dimetil-1,4-dihidro-1-6-naftiridin-3-karboksamida i njegovo pročišćavanje za upotrebu kao aktivni farmaceutski sastojak | |
| BRPI0714571A2 (pt) | processo para a produÇço de um composto, e, composto | |
| JP2013533267A5 (enExample) | ||
| JP2012251113A5 (enExample) | ||
| JP2013523699A5 (enExample) | ||
| JP2010524909A5 (enExample) | ||
| JP2014503001A5 (enExample) | ||
| PT2670751E (pt) | Métodos de fabrico de um composto profármaco inibidor da fixação do vih e intermediários | |
| JP2016503812A5 (enExample) | ||
| JP2014511387A5 (enExample) | ||
| CN117756801A (zh) | 一种非奈利酮的制备方法 | |
| CN104159884B (zh) | 通过使用水或多种酸作为添加剂的新型麦克尔加成反应制备化合物的方法 | |
| RU2012106722A (ru) | Производные стерина и их синтез и применение | |
| JP6251197B2 (ja) | 置換フェニルプロパノンを調製するためのプロセス | |
| JP6197868B2 (ja) | ピリダジノン化合物の製造方法 | |
| JP2004528380A (ja) | ゾルピデムの製造方法 | |
| TWI614256B (zh) | 合成四氫異喹啉噁唑烷的方法 | |
| JP6257115B2 (ja) | ３−アルキルチオ−２−ブロモピリジンの製造方法 | |
| CN103833717B (zh) | 一种奈必洛尔盐酸盐的合成方法 | |
| CN102153470B (zh) | 一种制备过酸酯化合物的方法 | |
| JP2012530834A5 (enExample) | ||
| CN103450092A (zh) | 一类甲硝唑-磺胺衍生物的合成及制备方法 | |
| CN102863341A (zh) | 一种（1r,2s）-2-芳基环丙胺衍生物的化学合成方法 | |
| KR20160049217A (ko) | 블로난세린 중간체의 신규 제조방법 |